Mudhar N Hasan
Overview
Explore the profile of Mudhar N Hasan including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
36
Followers
0
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Halawani A, Almehmadi S, Alhubaishy B, Alnefaie Z, Hasan M
Front Oncol
. 2024 Oct;
14:1457516.
PMID: 39391252
Background: The incorporation of Artificial Intelligence (AI) into healthcare sector has fundamentally transformed patient care paradigms, particularly through the creation of patient education materials (PEMs) tailored to individual needs. This...
2.
Corrales M, Hasan M, Carioti G, Emiliani E, Doizi S, Traxer O
World J Urol
. 2024 May;
42(1):280.
PMID: 38693433
Objective: To perform a comprehensive narrative review that will examine the risk factors and treatment outcomes of arterial pseudoaneurysm following laser flexible ureteroscopy (F-URS). Methods: A retrospective case series and...
3.
Meisl C, Karakiewicz P, Einarsson R, Koch S, Hallmann S, Weiss S, et al.
BJU Int
. 2021 Dec;
130(6):754-763.
PMID: 34928524
Objectives: To evaluate the clinical utility of the urinary bladder cancer antigen test UBC Rapid for the diagnosis of bladder cancer (BC) and to develop and validate nomograms to identify...
4.
Consultation on UTUC, Stockholm 2018 aspects of risk stratification: long-term results and follow-up
Hasan M, Roupret M, Keeley F, Cracco C, Jones R, Straub M, et al.
World J Urol
. 2019 Apr;
37(11):2289-2296.
PMID: 30944969
Purpose: To summarize current knowledge on upper urinary tract carcinoma (UTUC) regarding risk stratification, long-term results, and follow-up. Methods: A scoping review approach was applied to search literature in Pubmed,...
5.
Sherif A, Hasan M, Radecka E, Lozano Rodriguez A, Shabo S, Karlsson M, et al.
Scand J Urol
. 2015 Jul;
49(6):453-462.
PMID: 26144252
Objective: The aim of this study was to determine by computed tomography (CT) whether treatment with tumor-draining lymph-node-derived expanded autologous T lymphocytes results in objective responses and/or improved survival in...
6.
7.
Hasan M, Schumacher M, Wiklund P
Curr Opin Urol
. 2011 Oct;
21(6):483-7.
PMID: 21975509
Purpose Of Review: The use of robotic surgery in reconstructive urology has steadily increased since the year 2000. Articles in the MEDLINE database (from January 2000 to May 2011) identified...
8.
Sherif A, Hasan M, Marits P, Karlsson M, Winqvist O, Thorn M
Eur Urol
. 2009 Sep;
58(1):105-11.
PMID: 19766386
Background: Expected 2-yr survival for patients with urothelial urinary bladder cancer (UBC) with lymph node involvement (pN2) is 20%, regardless of standard neoadjuvant/adjuvant oncologic treatment. Tumor-reactive lymphocytes are present in...